Ana Langer
Other Academic

Ana Langer

Professor of the Practice of Public Health and Coordinator of the Dean's Special Initiative in Women and Health

Global Health and Population


The Women and Health Initiative is led by Dr. Ana Langer, a physician specializing in pediatrics and neonatology, and a reproductive health expert. She joined the Harvard T. H. Chan School of Public Health in July 2010 as a Professor of the Practice of Public Health in the Department of Global Health and Population. Dr. Langer is respected worldwide as a leader in reproductive and maternal health, the translation of evidence into policies and programs, the improvement of quality of health care for women and families. For more than 30 years, she has been a leading researcher, programmer and advocate for the improvement of women's health.

Dr. Langer has published extensively on maternal mortality; technical and interpersonal quality of maternal health care; unsafe abortion; contraception; the introduction of evidence-based practices in maternal health services; and strategies to strengthen women's reproductive rights. In 2015, in collaboration with experts from all over the world, Dr. Langer published the comprehensive report Women and Health: A key to sustainable development in The Lancet. The paper lays out the foundations of the women and health framework which analyzes women's health along the life cycle and its connections with social determinants of health and global transitions, and provides the evidence to fully demonstrate the critical roles women play as health care givers, and the development of communities and nations

Under Dr. Langer's leadership, the W&HI works on measurement of maternal health, sexual and reproductive health and rights in settings affected by conflict, maternal health and social support in the Greater Boston Area, and quality of maternal health care globally. In collaboration with the Harvard Global Health Institute, the W&HI coordinates the LEAD fellowship (Learn, Engage, Advance, Disrupt Fellowship), a novel program designed to promote leadership skills in individuals from low- and middle-income countries who will, in turn, mentor future female leaders in global health.

Recently, Dr. Langer and the W&HI became deeply involved in research and advocacy for maternal and reproductive health and women's rights in the COVID-19 era . The W&HI partners with the University of Oxford and multiple other organizations around the world on the INTERCOVID project, a prospective cohort study in pregnancy and the neonatal period that aims to provide women, families, health care providers and policymakers with high-quality evidence regarding the effects of COVID-19 infection on maternal, fetal and neonatal outcomes by carrying out a large, multi-national, prospective cohort study.

Dr. Langer teaches two courses at Harvard Chan School: GHP 231: Sexual Reproductive Health: Global Perspectives and GHP 547: Field Experience in Maternal Health. GHP 231 provides an overview of sexual and reproductive health and rights from a global perspective with a focus on the most disadvantaged populations. The course covers the critical topics in this field from diverse perspectives, including but not limited to historic, conceptual, research, methodological, policy, programmatic, and advocacy.

GHP 547 provides students with an opportunity to apply their skills and knowledge to maternal health issues in low- and middle-income countries through direct experiences with the Maternal Health Task Force partner organizations. Each student's experience is individually designed to meet the needs of both the student and the host organization.

Dr. Langer advises multiple masters and doctoral students working on women and maternal health issues.


Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study.

Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, Roggero P, Prefumo F, do Vale MS, Cardona-Perez JA, Maiz N, Cetin I, Savasi V, Deruelle P, Easter SR, Sichitiu J, Soto Conti CP, Ernawati E, Mhatre M, Teji JS, Liu B, Capelli C, Oberto M, Salazar L, Gravett MG, Cavoretto PI, Nachinab VB, Galadanci H, Oros D, Ayede AI, Sentilhes L, Bako B, Savorani M, Cena H, García-May PK, Etuk S, Casale R, Abd-Elsalam S, Ikenoue S, Aminu MB, Vecciarelli C, Duro EA, Usman MA, John-Akinola Y, Nieto R, Ferrazi E, Bhutta ZA, Langer A, Kennedy SH, Papageorghiou AT.

JAMA Pediatr. 2021 08 01. 175(8):817-826. PMID: 33885740


Improving maternal environments to boost health everywhere

Researchers from Harvard T.H. Chan School of Public Health are part of a new collaborative effort aimed at improving maternal health around the world by reducing toxic environments such as air pollution, stress, under-employment, lack of support and…

Why black women face a high risk of pregnancy complications

Black women are three to four times more likely to die from pregnancy-related complications than white women, according to the Centers for Disease Control and Prevention—and a big reason for the disparity may be racism, say experts. “It’s…

Zika epidemic response flawed, reports find

During Latin America’s recent epidemic of the mosquito-borne Zika virus, which peaked in early 2016, women’s sexual and reproductive rights were often ignored by governments throughout the region.